Andrew Moin
Directeur/Membre du Conseil chez SAB BIOTHERAPEUTICS, INC.
Profil
Andrew Moin is currently the Director at SAB Biotherapeutics, Inc. and an Analyst at Sessa Capital IM LP.
He is also a Member at The New York Bar Foundation.
Mr. Moin completed his undergraduate degree at Amherst College in 2005 and his graduate degree at Harvard Law School in 2008.
Postes actifs de Andrew Moin
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/10/2023 |
Sessa Capital IM LP
 Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Analyst-Equity | 01/08/2012 |
| The New York Bar Foundation | Corporate Officer/Principal | - |
Formation de Andrew Moin
| Amherst College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| The New York Bar Foundation | |
Sessa Capital IM LP
Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Finance |
